It has been classified either as a second-generation [1] or fourth-generation cephalosporin.[2]
It was patented in 1982 and approved for medical use in 1988 under the trade name Flumarin.[3]
References
^Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S (April 2008). "Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration". General Thoracic and Cardiovascular Surgery. 56 (4): 163–169. doi:10.1007/s11748-007-0208-5. PMID18401677. S2CID23845740.
^Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 (Suppl 5): S253 –S257. doi:10.1007/bf01645536. PMID1783441. S2CID25339977.